Home » Topics » BioWorld Science

BioWorld Science
RSS

LG Chem discloses new melanocortin MC4 receptor agonists

June 4, 2021

Betta Pharmaceuticals patents PI3K inhibitors

June 4, 2021

Karolinska announces that Dilafor successfully concluded its phase IIb study of tafoxiparin

June 4, 2021

Histogen provides development and pipeline updates

June 4, 2021

First patient dosed in phase I/II study of PhageBank in urinary tract infections

June 4, 2021

Algernon launches new clinical research program for ifenprodil in pancreatic cancer

June 4, 2021

Multi-characteristic opsin gene therapy restores clinically meaningful vision in patients with RP

June 4, 2021

Monopar and the National University of Singapore collaborate on development of MNPR-202

June 4, 2021

Hoth Therapeutics reports preclinical data for novel HT-KIT candidate

June 4, 2021

Oyster Point expands its pipeline and announces promising preclinical data

June 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...